Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06001294 |
|---|---|
| Brief Title: | We Collected Blood Samples From Septic Shock Patients and Measured ELABELA, Creatinine, and NGAL Levels. Survival After 7 Days Was Recorded and Analyzed to Evaluate the Potential of Serum ELABELA as an Early Diagnostic Marker for Sepsis-associated Acute Kidney Injury. (ELABELA（ELA）) |
| First Submitted : | August 14, 2023 |
| First Submitted that Met QC Criteria : | August 14, 2023 |
| First Posted : | August 21, 2023 |
| Last Update Submitted that Met QC Criteria : | August 19, 2023 |
| Last Update Posted : | August 22, 2023 |